Cytek Biosciences, Inc. (CTKB)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation

Ask a question about Cytek Biosciences, Inc. (CTKB)

Company Performance

Current Price

as of Oct 21, 2024

$5.14

P/E Ratio

N/A

Market Cap

$675.94M

Description

Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC. The company was founded by Wenbin Jiang and Ming Yan in 1992 and is headquartered in Fremont, CA.

Metrics

Overview

HQFremont, CA
SectorHealth Technology
IndustryMedical Specialties
TickerCTKB
Price$5.14-0.58%

Trading Information

Market Cap$675.94M
Float90.79%
Average Daily Volume (1m)481,982
Average Daily Volume (3m)605,230
EPS-$0.13

Company

Revenue$197.71M
Rev Growth (1yr)-6.19%
Net Income-$10.43M
Gross Margin54.56%
EBITDA Margin-12.97%
EBITDA-$6.05M

EV$489.39M
EV/Revenue2.48
P/EN/A
P/S3.42
P/B1.74

Documents

Factset Street Account

StreetAccount Earnings Call Q&A Summary: Cytek Biosciences Q3 (2023-11-08T11:11:42Z)

Cytek Biosciences reports Q3 EPS ($0.05) vs FactSet $0.02 [5 est, ($0.01)-0.07] ($4.45, 0.00) (2023-11-07T21:20:00Z)

Cytek Biosciences discloses delay in filing of its Q3 10-Q; expects to file on or before 14-Nov - NT 10-Q ($4.96, 0.00) (2023-11-13T21:35:32Z)

Earnings Calls

Earnings Report 2024Q2

Earnings Report 2024Q1

Earnings Report 2023Q4

Earnings Report (2023-11-11)

Earnings Report (2023-08-12)